| Nerves jangle over report into Shire's ADHD drug |
The Independent by Nikhil Kumar, Jul 31, 2010 |
| Shire slips after downgrade while FTSE fades on US GDP data |
guardian.co.uk by Nick Fletcher Jul 30, 2010 |
| Boredom-busting free summer holiday evening fun kicks off |
basingstoke.gov.uk Jul 27, 2010 |
| Supporting act wins an award |
Basingstoke Gazette, Jul 22, 2010 |
| Shire rises after Credit Suisse upgrade |
Reuters, July 14, 2010 |
| Shire higher; Evolution starts as "buy" |
Reuters, July 12, 2010 |
| Another drug giant bringing jobs to Mass. |
The Boston Globe by Todd Wallack, July 8, 2010 |
| Shire files patent lawsuit against Cadila |
Associated Press, July 8, 2010 |
| UBS Cuts Shire Pharmaceuticals Price Target |
Dow Jones, July 7, 2010 |
| UPDATE 1-EU drugs body recommends Shire's Fabry treatment |
Reuters by Paul Sandle and Kate Kelland, July 6, 2010 |
| FDA Says Intuniv Promotional Materials are 'Misleading' |
Drugs.com, July 2, 2010 |
| Shire pays $165m for Lexington site |
The Boston Globe, July 1, 2010 |
| Short Attention Span? Shire Cited Again For Out-Of-Bounds ADHD Promotion |
The Pink Sheet DAILY, July 1, 2010 |
| Shire Overstates Benefits of Intuniv, U.S. FDA Says |
Bloomberg by Molly Peterson, June 30, 2010 |
| Shire braced for US study into heart risks of attention deficit drug |
Guardian by Richard Wachman, June 27, 2010 |
| No free pens but pharma influence still felt at psychiatric meeting |
Online Journal by Martha Rosenberg, Jun 3, 2010 |
| Shire's 'unflappable' CEO a foe of inertia |
Fierce Pharma by Tracy Staton, Jun 1, 2010 |
| Interview with Angus Russell, CEO of Shire |
Sunday Times by Andrew Davidson, May 30, 2010 |
| Shire pays $200m for lab buildings |
The Boston Globe by Casey Ross, May 28, 2010 |
| Orphan Drugs: Small Patient Base, Big Opportunity |
Fool.com by Brian Orelli, May 25, 2010 |
| Shire spent $150,000 lobbying the federal government in the 1st quarter |
Associated Press May 24, 2010 |
| Video: The Big give in Chesterbrook |
mainlinemedianews.com May 24, 2010 |
| Shire Pharmaceuticals hosts BIG GIVE |
Daily Times, May 21, 2010 |
| Une pharma internationale s’implante à Eysin |
L’Agefi - 21 mai 2010 |
| Shire va ouvrir un bureau près de Nyon |
Le Temps - Mathilde Farine - 21 mai 2010 |
| Interview with Angus Russell |
CNBC UK, Strictly Money, May 20, 2010 |
| Shire down; JP Morgan cuts to "neutral" |
Reuters UK, May 13, 2010 |
| UPDATE 1-US warns Roche, Shire on misleading drug promotions |
Reuters May 5, 2010 |
| Shire lifted by American take-up of ADHD drug |
Times Online by Emily Ford Apr 30, 2010 |
| Biotech cos. embrace a hiring culture |
Boston Business Journal by Julie Donnelly Apr 30, 2010 |
| Shire beats forecasts as new drugs plug gap left by generic competition |
Telegraph by Rachel Cooper Apr 30, 2010 |
| Shire Sees Some Benefits From US Healthcare Overhaul |
Dow Jones by Jason Douglas Apr 29, 2010 |
| Shire First-Quarter Profit Falls Less Than Forecast (Update2) |
Bloomberg by Michelle Fay Cortez Apr 29, 2010 |
| UPDATE 3-Shire Q1 beats forecasts, repeats growth target |
Reuters by Paul Sandle Apr 29, 2010 |
| New drugs fill the gap at Shire |
FT.com by John O’Doherty Apr 29, 2010 |
| Shire sues Teva over generic ADHD drug Intuniv |
Associated Press Apr 23, 2010 |
| UPDATE: EU Drug Body: Consider Switching To Shire Fabry Drug |
Dow Jones by Jason Douglas Apr 23, 2010 |
| Bosses stir up executive pay row with mega salary packages |
guardian.co.uk by Richard Wray Apr 11, 2010 |
